Duodenal Dieulafoy’s Lesion-arising Awareness of this Rare Cause of Gastrointestinal Bleed

Harshavardhan Sanekommu *

Jersey Shore University Medical Center, Department of Medicine 1945 NJ-33, Neptune City, NJ-07753, USA.

Andrea Morris

School of Medicine, Saint George’s University, West Indies, Grenada.

Sobaan Taj

Jersey Shore University Medical Center, Department of Medicine 1945 NJ-33, Neptune City, NJ-07753, USA.

Rida Mah Noor

International University of Kyrgyzstan-International School of Medicine, Eastern Campus. Bishkek, Kyrgyzstan.

Muhammad Umair Akmal

Kazakh National Medical University, Almaty, Kazakhstan.

Pranav Shah

Jersey Shore University Medical Center, Department of Radiology, 1945 NJ-33, Neptune City, NJ-07753, USA.

Mohammed Hossain

Jersey Shore University Medical Center, Department of Medicine 1945 NJ-33, Neptune City, NJ-07753, USA.

Arif Asif

Jersey Shore University Medical Center, Department of Medicine 1945 NJ-33, Neptune City, NJ-07753, USA.

*Author to whom correspondence should be addressed.


Abstract

Aim: The aim of this report is to raise awareness about the risk of bleeding associated with duodenal Dieulafoy lesions (DLs) and to emphasize the importance of utilizing imaging modalities when DLs are suspected as the cause of bleeding.

Presentation: This case study reports a 68-year-old male who presented with non-bloody vomiting and multiple episodes of hematochezia. An angiogram revealed active bleeding in the duodenum, which was subsequently identified and treated on the first attempt during endoscopy as a bleeding duodenal DL.

Discussion: DLs are a rare cause of gastrointestinal bleeding, characterized by dilated submucosal vessels that have a tortuous path, making them susceptible to erosion. They are most commonly found in the stomach, and are extremely rare in the duodenum, often requiring multiple endoscopic attempts to identify and treat. However, we were able to successfully treat our patient upon the first attempt with the help of angiogram prior to endoscopy.  Use of multiple methods to achieve hemostasis (epinephrine injection, heat probe, and hemoclips) is effective in treating DLs. 

Conclusion: It is important to recognize DLs as a potential cause of gastrointestinal bleeding, given their high mortality rate. The use of imaging prior to endoscopy can potentially prevent the need for multiple attempts at identifying and treating the lesion.

Keywords: Duodenal Dieulafoy’s lesion, endoscopy, upper gastrointestinal bleed, hemoclipping, heat probe, epinephrine injection


How to Cite

Sanekommu, H., Morris , A., Taj, S., Noor, R. M., Akmal , M. U., Shah, P., Hossain, M., & Asif , A. (2023). Duodenal Dieulafoy’s Lesion-arising Awareness of this Rare Cause of Gastrointestinal Bleed. Asian Journal of Research and Reports in Gastroenterology, 6(1), 6–10. Retrieved from https://journalajrrga.com/index.php/AJRRGA/article/view/91


References

Yılmaz TU, Kozan R. Duodenal and jejunal Dieulafoy’s lesions: optimal management. Clin Exp Gastroenterol. 2017;10:275–83. Available:https://doi.org/10.2147/CEG.S122784.

Morowitz MJ, Markowitz R, Kamath BM, von Allmen D. Dieulafoy’s lesion and segmental dilatation of the small bowel: an uncommon cause of gastrointestinal bleeding. J Pediatr Surg. 2004;39:1726–8. Available:https://doi.org/10.1016/j.jpedsurg.2004.07.027.

Sai Prasad TR, Lim KH, Lim KH, Yap T-L. Bleeding jejunal Dieulafoy pseudopolyp: capsule endoscopic detection and laparoscopic-assisted resection. J Laparoendosc Adv Surg Tech A. 2007;17: 509–12. Available:https://doi.org/10.1089/lap.2006.0063.

Chaer RA, Helton WS. Dieulafoy’s disease. J Am Coll Surg. 2003;196:290–6. Available: https://doi.org/10.1016/S1072-7515(02)01801-X.

Baxter M, Aly EH. Dieulafoy’s lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010;92:548–54. Available:https://doi.org/10.1308/003588410X12699663905311.

Norton ID, Petersen BT, Sorbi D, Balm RK, Alexander GL, Gostout CJ. Management and long-term prognosis of Dieulafoy lesion. Gastrointest Endosc. 1999;50: 762–7. Available: https://doi.org/10.1016/s0016-5107(99)70155-0.

Stark ME, Gostout CJ, Balm RK. Clinical features and endoscopic management of Dieulafoy’s disease. Gastrointest Endosc 1992;38:545–50. Available: https://doi.org/10.1016/s0016-5107(92)70513-6.

Veldhuyzen van Zanten SJ, Bartelsman JF, Schipper ME, Tytgat GN. Recurrent massive haematemesis from Dieulafoy vascular malformations-- a review of 101 cases. Gut. 1986;27: 213–22. Available:https://doi.org/10.1136/gut.27.2.213.

Schmulewitz N. Dieulafoy lesions: a review of 6 years of experience at a tertiary referral center. Am J Gastroenterol. 2001;96:1688–94. Available: https://doi.org/10.1016/S0002-9270(01)02485-6.

Chung IK, Kim EJ, Lee MS, Kim HS, Park SH, Lee MH, et al. Bleeding Dieulafoy’s lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc. 2000;52: 721–4. Available:https://doi.org/10.1067/mge.2000.108040.